Menu
Home
About Us
Who We Are
Purpose & Values
Board
Partners
Distributors
Compliance
Careers
Technology
Our Solution
Technology Introduction
Platform Technology
Publications
Image Gallery
Webinars
FAQ
Products
Our Products
InVivage
ViewnVivo
Customisation
Pipeline
Investor
Investor Overview
ASX Announcements
Reports
Share Price Information
Financial Calendar
Media Coverage
Sustainability
Share Registry
Investor Alerts
Media
News
Social Media Feed
Contact
Contact
Select Category
Clinical Research
Oral cancer diagnosis and surgical margin
Brain cancer
General surgery
Cervical assessment
Gastrointestinal assessment
Life Sciences Research
Cell viability
Live antibody labelling
Intraoperative surgery and tumour margin delineation
Blood vessel, perfusion, and barrier function
Live microflora imaging
Nano particle and drug delivery
Proof of concept in live models
Recent Posts
Optiscan in the news: Optiscan Imaging to transform digital pathology
Optiscan in the news: Optiscan Imaging completes beta phase testing of cloud-based telepathology platform
Optiscan in the news: Optiscan reveals new breakthrough on remote pathology technology
Optiscan in the news: Telepathology milestone as Optiscan gets set for commerciality
Optiscan in the news: Getting a clear snapshot in breast cancer surgery study
Archives
July 2024
June 2024
May 2024
April 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
November 2022
September 2022
February 2022
May 2021
Categories
Announcements
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Veterinary
Optiscan in the news: Optiscan Imaging to transform digital pathology
July 30th, 2024 by Leah Sneddon
Read More
Optiscan in the news: Optiscan Imaging completes beta phase testing of cloud-based telepathology platform
July 29th, 2024 by Leah Sneddon
Read More
Optiscan in the news: Optiscan reveals new breakthrough on remote pathology technology
July 29th, 2024 by Leah Sneddon
Read More
Optiscan in the news: Telepathology milestone as Optiscan gets set for commerciality
July 29th, 2024 by Leah Sneddon
Read More
Optiscan in the news: Getting a clear snapshot in breast cancer surgery study
July 23rd, 2024 by Leah Sneddon
Read More
Optiscan Receives Ethical Clearance for Breast Cancer Study
July 15th, 2024 by Leah Sneddon
Read More
Optiscan in the news: ‘Significant milestone’: Optiscan soars on new InVue imaging device for precision surgery
June 4th, 2024 by Leah Sneddon
Read More
Optiscan in the news - Hoof on the till: Peters backs Optiscan med-tech
May 27th, 2024 by Leah Sneddon
Read More
Optiscan in the news: Optiscan Imaging: Innovation in the heart of Hotham!
May 23rd, 2024 by Leah Sneddon
Read More
Optiscan Investor Webinar recording - May 2024
May 23rd, 2024 by Leah Sneddon
Read More
Long Shortz with Optiscan Imaging: Life-saving deal with Mayo Clinic years in the making
May 20th, 2024 by Leah Sneddon
Read More
Optiscan and Mayo Clinic join forces for groundbreaking advancement in pathology
May 14th, 2024 by Leah Sneddon
Read More
Optiscan extends robotic arm with US medical imaging deal
May 13th, 2024 by Leah Sneddon
Read More
ASX medtechs poised to transform healthcare with 2024 catalysts – Part 1.
April 30th, 2024 by Brendan Fafiani
Read More
Optiscan completes ANDHealth Activate Program
December 7th, 2023 by
Read More
Optiscan’s Platform could address Global Pathologist Shortage
November 19th, 2023 by
Read More
‘Diagnose on the spot’: Optiscan’s Platform brings together Surgeons and Pathologists for Better Cancer Outcomes
October 30th, 2023 by
Read More
Optiscan Moves to Stamp Stronger US Footprint
October 12th, 2023 by
Read More
Optiscan on Cusp of Real-Time Cancer Imaging Breakthrough
September 19th, 2023 by
Read More
Nod of approval: Optiscan deal boosts revenue by 66%
September 1st, 2023 by
Read More
1
2
3
Back to All Publications
